Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Sens ; 6(9): 3462-3467, 2021 09 24.
Article in English | MEDLINE | ID: mdl-34432415

ABSTRACT

Sulfur-substituted biocompatible carbonyl fluorophores have been recognized as effective heavy-atom-free photosensitizers (PSs) for cancer therapy due to their remarkable phototherapeutic properties. However, guidelines on their molecular design are still a substantial challenge. Most of the existing thiocarbonyl-based PSs are nonemissive in both the solution and restricted states, which hinders their further biomedical applications. Herein, we report the interesting finding that sulfur-substituted coumarins exhibit an uncommon phenomenon, aggregation-induced emission. More intriguingly, we also found that the introduction of a strong electron-accepting trifluoromethyl group is crucial to facilitate the mitochondrial-targeting ability of neutral coumarin fluorophores. The resulting CMS-2 PS displayed selective imaging of mitochondria and exhibited much higher photodynamic therapy efficiency toward cancer cells than that of the commercial PS erythrosine B. This work provides deep insight into the molecular design of heavy-atom-free thiobase-based PSs and simultaneously offers a great opportunity to develop novel mitochondrial-targeting fluorescent indicators with neutral bioinspired platforms.


Subject(s)
Neoplasms , Precision Medicine , Neoplasms/drug therapy , Photosensitizing Agents
2.
ACS Appl Mater Interfaces ; 13(12): 13949-13957, 2021 Mar 31.
Article in English | MEDLINE | ID: mdl-33729767

ABSTRACT

In this article, we designed and synthesized the thionated NpImidazole derivatives BS and NS, new heavy-atom-free photosensitizers, which efficiently generate a triplet excited state with high singlet oxygen quantum yield. The introduction of the C═S bond to the NpImidazole core is essential for increasing spin-orbit coupling (SOC). The fluorescence emission of BS and NS was quenched at standard ambient temperature, accompanied with the increase in the ISC process from the singlet states to triplet excited states via thionation. BS and NS showed negligible dark cytotoxicity against HeLa cells in working concentration. In contrast, BS and NS rapidly induced cell death under blue light irradiation both under normoxia and hypoxia conditions. Our current study demonstrates that the C═S group can play an important role in type I ROS generation of PSs, which are unprecedented in the previous reports. Finally, the photophysical changes were assigned to the oxidative desulfurization of the C═S group of BS and NS to the C═O group of the corresponding BO and NO via hypochlorite. The combined results demonstrated the dual function of BS and NS as a fluorescent imaging agent for ClO- and an anti-cancer therapeutic by PDT that showed the potential strategy for "one-for-all" and multifunctional agents.


Subject(s)
Fluorescent Dyes/chemistry , Hypochlorous Acid/analysis , Imidazoles/chemistry , Photosensitizing Agents/chemistry , Thiones/chemistry , Drug Design , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/pharmacology , HeLa Cells , Humans , Imidazoles/chemical synthesis , Imidazoles/pharmacology , Models, Molecular , Neoplasms/drug therapy , Neoplasms/pathology , Optical Imaging , Photochemotherapy , Photosensitizing Agents/chemical synthesis , Photosensitizing Agents/pharmacology , Thiones/chemical synthesis , Thiones/pharmacology , Tumor Hypoxia/drug effects
3.
Chem Commun (Camb) ; 56(77): 11489-11492, 2020 Sep 29.
Article in English | MEDLINE | ID: mdl-32857074

ABSTRACT

Novel thiocarbonyl derivatives (NIS and CRNS) with excellent ROS generation abilities are synthesized and studied as potential photosensitizers for one- and two-photon excited photodynamic therapy. In particular, NIS-Me and CRNS display outstanding phototoxicity toward HeLa cells under two-photon excitation (800 nm) with negligible dark toxicity.


Subject(s)
Antineoplastic Agents/pharmacology , Drug Design , Photochemotherapy , Photosensitizing Agents/pharmacology , Sulfhydryl Compounds/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Screening Assays, Antitumor , HeLa Cells , Humans , Molecular Structure , Optical Imaging , Photosensitizing Agents/chemical synthesis , Photosensitizing Agents/chemistry , Sulfhydryl Compounds/chemical synthesis , Sulfhydryl Compounds/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...